Cargando…

Diagnosis and treatment of new heart failure with reduced ejection fraction by the artificial intelligence–enhanced electrocardiogram

Detalles Bibliográficos
Autores principales:	Harmon, David M., Witt, Daniel R., Friedman, Paul A., Attia, Zachi I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890344/ https://www.ncbi.nlm.nih.gov/pubmed/35265919 http://dx.doi.org/10.1016/j.cvdhj.2021.08.002

Ejemplares similares

Clinical trial design data for electrocardiogram artificial intelligence-guided screening for low ejection fraction (EAGLE)
por: Yao, Xiaoxi, et al.
Publicado: (2019)

A comprehensive artificial intelligence–enabled electrocardiogram interpretation program
por: Kashou, Anthony H., et al.
Publicado: (2020)

Real-world performance, long-term efficacy, and absence of bias in the artificial intelligence enhanced electrocardiogram to detect left ventricular systolic dysfunction
por: Harmon, David M, et al.
Publicado: (2022)

Recurrent cryptogenic stroke: A potential role for an artificial intelligence–enabled electrocardiogram?
por: Kashou, Anthony H., et al.
Publicado: (2020)

Automated detection of low ejection fraction from a one-lead electrocardiogram: application of an AI algorithm to an electrocardiogram-enabled Digital Stethoscope( )
por: Attia, Zachi I, et al.
Publicado: (2022)

Artificial Intelligence-Enhanced Smartwatch ECG for Heart Failure-Reduced Ejection Fraction Detection by Generating 12-Lead ECG
por: Kwon, Joon-myoung, et al.
Publicado: (2022)

Correlation between artificial intelligence-enabled electrocardiogram and echocardiographic features in aortic stenosis
por: Ito, Saki, et al.
Publicado: (2023)

Community-based participatory research application of an artificial intelligence-enhanced electrocardiogram for cardiovascular disease screening: A FAITH! Trial ancillary study
por: Harmon, David M., et al.
Publicado: (2022)

Artificial intelligence-enhanced electrocardiography in cardiovascular disease management
por: Siontis, Konstantinos C., et al.
Publicado: (2021)

Importance of external validation and subgroup analysis of artificial intelligence in the detection of low ejection fraction from electrocardiograms
por: Yagi, Ryuichiro, et al.
Publicado: (2022)

Artificial intelligence-enabled electrocardiogram screens low left ventricular ejection fraction with a degree of confidence
por: Lee, Chun-Ho, et al.
Publicado: (2022)

Electrocardiogram-Artificial Intelligence and Immune-Mediated Necrotizing Myopathy: Predicting Left Ventricular Dysfunction and Clinical Outcomes
por: Klein, Christopher J., et al.
Publicado: (2022)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Vericiguat for Heart Failure with Reduced Ejection Fraction
por: Lombardi, Carlo Mario, et al.
Publicado: (2021)

Management of heart failure with reduced ejection fraction
por: Haydock, Paul M, et al.
Publicado: (2022)

Deep learning detects heart failure with preserved ejection fraction using a baseline electrocardiogram
por: Unterhuber, Matthias, et al.
Publicado: (2021)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence
por: Bayes-Genis, Antoni, et al.
Publicado: (2021)

Artificial intelligence assessment for early detection of heart failure with preserved ejection fraction based on electrocardiographic features
por: Kwon, Joon-myoung, et al.
Publicado: (2020)

Comparison of Electrocardiographic Parameters by Gender in Heart Failure Patients with Preserved Ejection Fraction via Artificial Intelligence
por: Yilmaz, Rustem, et al.
Publicado: (2023)

Role of interleukins in heart failure with reduced ejection fraction
por: Segiet, Oliwia Anna, et al.
Publicado: (2019)

Updates in pharmacotherapy of heart failure with reduced ejection fraction
por: Espinoza, Clifton, et al.
Publicado: (2021)

Editorial: Edema in heart failure with reduced ejection fraction
por: Gladysheva, Inna P., et al.
Publicado: (2023)

Deep neural networks learn by using human-selected electrocardiogram features and novel features
por: Attia, Zachi I, et al.
Publicado: (2021)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
por: Miller, Robert J.H., et al.
Publicado: (2022)

Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction
por: Shahnazaryan, Syuzanna, et al.
Publicado: (2023)

Heart Failure With Preserved Ejection Fraction vs. Reduced Ejection Fraction　― Mechanisms of Ventilatory Inefficiency During Exercise in Heart Failure ―
por: Tsujinaga, Shingo, et al.
Publicado: (2020)

Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2021)

Pragmatic considerations for fostering reproducible research in artificial intelligence
por: Carter, Rickey E., et al.
Publicado: (2019)

Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach
por: Mele, Marco, et al.
Publicado: (2023)

Rapid Exclusion of COVID Infection With the Artificial Intelligence Electrocardiogram
por: Attia, Zachi I., et al.
Publicado: (2021)

Therapeutic implications of statins in heart failure with reduced ejection fraction and heart failure with preserved ejection fraction: a review of current literature
por: Techorueangwiwat, Chol, et al.
Publicado: (2021)

Subtle QRS changes are associated with reduced ejection fraction, diastolic dysfunction, and heart failure development and therapy responsiveness: Applications for artificial intelligence to ECG
por: García‐Escobar, Artemio, et al.
Publicado: (2022)

Prognosis of patients with heart failure and reduced ejection fraction in China
por: XU, YU, et al.
Publicado: (2013)

The concentration of interleukin-33 in heart failure with reduced ejection fraction
por: Anna Segiet, Oliwia, et al.
Publicado: (2019)

Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
por: Al‐Mohammad, Abdallah
Publicado: (2019)

Risk stratification in heart failure with mild reduced ejection fraction
por: Magrì, Damiano, et al.
Publicado: (2020)

Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction
por: Rossitto, Giacomo, et al.
Publicado: (2020)

Heart failure with reduced ejection fraction due topolycythemia vera
por: Zaman, Muhammad Omer, et al.
Publicado: (2021)

Heart failure with mid-range or mildly reduced ejection fraction
por: Savarese, Gianluigi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hvjordn2rto0cubqd0956tkm71